Joel O. Cresser-Brown
Joel O. Cresser-Brown has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Graham P. Marsh
Bio-Techne (Tocris), The Watkins Building, Atlantic Road, Avonmouth, Bristol BS11 9QD, U.K.
3 shared publications - Hannah Jane Maple
Bio-Techne (Tocris), The Watkins Building, Atlantic Road, Avonmouth, Bristol BS11 9QD, U.K.
3 shared publications Mark C. Norley
Bio-Techne (Tocris), The Watkins Building, Avonmouth, Bristol, BS11 9QD, UK
2 shared publicationsMark S. Cooper
Bio-Techne (Tocris), The Watkins Building, Atlantic Road, Avonmouth, Bristol, BS11 9QD, UK
2 shared publicationsRobert E. Arnold
Bio-Techne (Tocris), The Watkins Building, Avonmouth, Bristol, BS11 9QD, UK
2 shared publications- Sean Goggins
Department of Chemistry, University of Bath, Bath, UK
2 shared publications
Latest Publications
- Open Access
BromoCatch: a self-labelling tag platform for protein analysis and live cell imaging
Visualizing and manipulating proteins in live cells is crucial for studying complex biological processes. Self-labelling protein (SLP) tags such as HaloTag and SNAP-tag can be fused to genes of interest to allow protein labelling in cells. Limitations including size of the tag and suboptimal fitness of reactivity motivate development of improved tools to enable rapid, specific and stable protein labelling. We present BromoCatch, a novel SLP platform based on a small ∼13 kDa bromodomain (BD) engineered with a nucleophilic cysteine for covalent ligand engagement. A structure-based designed library of 16 “bumped” binders bearing diverse electrophilic warheads was screened against two different cysteine mutants using differential scanning fluorimetry and intact protein mass spectrometry to monitor covalent complex formation. The para-acrylamide bumped derivative MR116 and the Brd4-BD2 double mutant L387A,E438C formed the most potent and stable adduct, and its binding mode through covalent modification was confirmed by an X-ray cocrystal structure solved to 1.3 Å of resolution. BromoCatch exhibited potent and irreversible target engagement in cells through nanoBRET and residence time assays. Practicality and scope are further demonstrated through the design and proof-of-concept application of a biotinylated conjugate, PROTAC tag degraders, and fluorescent probes of both full-on and switch-on types for ex-cellulo and live-cell imaging. Together, we qualify BromoCatch as a novel, versatile and efficient protein labelling tool and technology platform. Its advantageous design features and kinetic fitness, and its modular design enabling diverse functionalities, are anticipated to usher a range of future applications and witness broad utility.
Open AccessBromoCatch: a self-labelling tag platform for protein analysis and live cell imaging
Visualizing and manipulating proteins in live cells is crucial for studying complex biological processes. Self-labelling protein (SLP) tags such as HaloTag and SNAP-tag can be fused to genes of interest to allow protein labelling in cells. Limitations including size of the tag and suboptimal fitness of reactivity motivate development of improved tools to enable rapid, specific and stable protein labelling. We present BromoCatch, a novel SLP platform based on a small ∼13 kDa bromodomain (BD) engineered with a nucleophilic cysteine for covalent ligand engagement. A structure-based designed library of 16 “bumped” binders bearing diverse electrophilic warheads was screened against two different cysteine mutants using differential scanning fluorimetry and intact protein mass spectrometry to monitor covalent complex formation. The para-acrylamide bumped derivative MR116 and the Brd4-BD2 double mutant L387A,E438C formed the most potent and stable adduct, and its binding mode through covalent modification was confirmed by an X-ray cocrystal structure solved to 1.3 Å of resolution. BromoCatch exhibited potent and irreversible target engagement in cells through nanoBRET and residence time assays. Practicality and scope are further demonstrated through the design and proof-of-concept application of a biotinylated conjugate, PROTAC tag degraders, and fluorescent probes of both full-on and switch-on types for ex-cellulo and live-cell imaging. Together, we qualify BromoCatch as a novel, versatile and efficient protein labelling tool and technology platform. Its advantageous design features and kinetic fitness, and its modular design enabling diverse functionalities, are anticipated to usher a range of future applications and witness broad utility.
- Open Access
- 3 March 2025
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 16 (5) , 2049-2060
Development of p300-targeting degraders with enhanced selectivity and onset of degradation
P300 and CBP are paralogous epigenetic regulators and promising therapeutic targets for which TPD offers the potential to achieve paralog-selective degradation.
- 3 March 2025
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 16 (5) , 2049-2060
Open AccessDevelopment of p300-targeting degraders with enhanced selectivity and onset of degradation
P300 and CBP are paralogous epigenetic regulators and promising therapeutic targets for which TPD offers the potential to achieve paralog-selective degradation.
- 4 October 2023
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 21 (41) , 8344-8352
Efficient, multi-hundred-gram scale access to E3 ubiquitin ligase ligands for degrader development
Supporting degrader discovery programs in scale and scope: facile access to multi-hundred-gram quantities of the common E3 ligase ligands.
- 4 October 2023
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 21 (41) , 8344-8352
Efficient, multi-hundred-gram scale access to E3 ubiquitin ligase ligands for degrader development
Supporting degrader discovery programs in scale and scope: facile access to multi-hundred-gram quantities of the common E3 ligase ligands.